ERBB2 and breast cancer: Immunofluorescent staining revealed that DVL2 exhibited higher expression in HER2+ breast cancer tissues compared to the adjacent tissues and Kaplan Meier survival curves analysis revealed that increased DVL2 expression was associated with poor overall survival, hence poor prognosis in HER2+ breast cancer patients.